IL160871A0 - A combination of spirolactone and angiostensin ii receptor agonist - Google Patents

A combination of spirolactone and angiostensin ii receptor agonist

Info

Publication number
IL160871A0
IL160871A0 IL16087196A IL16087196A IL160871A0 IL 160871 A0 IL160871 A0 IL 160871A0 IL 16087196 A IL16087196 A IL 16087196A IL 16087196 A IL16087196 A IL 16087196A IL 160871 A0 IL160871 A0 IL 160871A0
Authority
IL
Israel
Prior art keywords
angiostensin
spirolactone
combination
receptor agonist
agonist
Prior art date
Application number
IL16087196A
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Priority claimed from PCT/US1996/009342 external-priority patent/WO1996040258A2/en
Publication of IL160871A0 publication Critical patent/IL160871A0/en

Links

IL16087196A 1995-06-07 1996-06-05 A combination of spirolactone and angiostensin ii receptor agonist IL160871A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48608995A 1995-06-07 1995-06-07
PCT/US1996/009342 WO1996040258A2 (en) 1995-06-07 1996-06-05 Spironolactone and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
IL12224696A IL122246A (en) 1995-06-07 1996-06-05 Spironolactone and angiotensin ii antagonist combination for treatment of congestive heart failure

Publications (1)

Publication Number Publication Date
IL160871A0 true IL160871A0 (en) 2004-08-31

Family

ID=34082126

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16087196A IL160871A0 (en) 1995-06-07 1996-06-05 A combination of spirolactone and angiostensin ii receptor agonist

Country Status (1)

Country Link
IL (1) IL160871A0 (en)

Similar Documents

Publication Publication Date Title
ZA964744B (en) Crf receptor antagonists and methods relating thereto
PL321538A1 (en) Additional protein of a human interleukin-1 receptor
IL135375A0 (en) Dihydro and tetrahydroisoquinoline derivatives
GB9605507D0 (en) A method of making and a device including a titanium nitride layer
EP0815137A4 (en) Human g-protein chemokine receptor hdgnr10
EP0817800A4 (en) Human g-protein coupled receptors
IL117988A0 (en) A new combination of an inhibitor and an antagonist
EP0832125A4 (en) Human g-protein receptor hgber32
PL328633A1 (en) Oxazolic and thiadizolic antagonists of muscarinic receptors
GB2307168B (en) Shoulder anchor structure
NZ300198A (en) Preparation of n-arylhydroxylamines and n-hetarylhydroxylamines
EP1015473A4 (en) CLONING AND EXPRESSION OF betaAPP-C100 RECEPTOR (C100-R)
GB9517098D0 (en) Receptor
GB9521696D0 (en) Combination of LTD4 receptor antagonists with glucocorticosteriods
EP0836617A4 (en) Parevins and tachytegrins
IL118295A0 (en) 3-(2- trialkylsilyloxy) ethyl-7-ethyl-1H- indoles and their preparation
PL320638A1 (en) Antagonists of endothein receptors
IL118299A0 (en) Pharmacological use of AII-receptor antagonists
HU9602127D0 (en) Endotheline receptor antagonists
EP0832126A4 (en) G-protein receptor htnad29
AU4014195A (en) Activation of a human steroid receptor
EP0835264A4 (en) Human g-protein receptor hcegh45
IL160871A0 (en) A combination of spirolactone and angiostensin ii receptor agonist
IL124430A0 (en) An envelope and an envelope construction
EP0812329A4 (en) Human g-protein coupled receptor